WI
GSK icon

Wintrust Investments’s GSK GSK Stock Holding History

Wintrust Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$21K Sell
645
-547
-46% -$19.7K 0.02% 385
2024
Q3 		$48K Sell
1,192
-12,055
-91% -$493K 0.04% 313
2024
Q2 		$510K Hold
13,247
– – 0.04% 283
2024
Q1 		$568K Sell
13,247
-779
-6% -$32.1K 0.05% 265
2023
Q4 		$520K Sell
14,026
-169
-1% -$6.07K 0.05% 266
2023
Q3 		$515K Sell
14,195
-636
-4% -$22.6K 0.05% 254
2023
Q2 		$529K Sell
14,831
-781
-5% -$28K 0.05% 262
2023
Q1 		$555K Sell
15,612
-3,435
-18% -$120K 0.07% 194
2022
Q4 		$669K Sell
19,047
-1,637
-8% -$54.5K 0.09% 177
2022
Q3 		$609K Sell
20,684
-730
-3% -$27.7K 0.08% 201
2022
Q2 		$1.17M Sell
21,414
-1,624
-7% -$89.7K 0.14% 137
2022
Q1 		$1.25M Sell
23,038
-6,000
-21% -$326K 0.12% 148
2021
Q4 		$1.6M Buy
+29,038
New +$1.51M 0.15% 122
2021
Q3 		– Sell
-5,778
Closed -$427K – 335
2021
Q2 		$427K Sell
5,778
-33,307
-85% -$1.6M 0.04% 282
2021
Q1 		$1.74M Buy
39,085
+16,329
+72% +$741K 0.18% 115
2020
Q4 		$1.05M Buy
22,756
+7,447
+49% +$342K 0.3% 69
2020
Q3 		$720K Buy
15,309
+9,156
+149% +$459K 0.1% 152
2020
Q2 		$314K Buy
6,153
+323
+6% +$16.6K 0.04% 266
2020
Q1 		$276K Buy
5,830
+19
+0.3% +$1.01K 0.05% 249
2019
Q4 		$341K Buy
5,811
+278
+5% +$15.5K 0.05% 267
2019
Q3 		$295K Buy
5,533
+417
+8% +$21.5K 0.04% 285
2019
Q2 		$256K Sell
5,116
-606
-11% -$30.4K 0.04% 313
2019
Q1 		$299K Buy
5,722
+1,312
+30% +$65.6K 0.05% 270
2018
Q4 		$211K Buy
+4,410
New +$217K 0.04% 306
2018
Q2 		– Sell
-4,166
Closed -$203K – 355
2018
Q1 		$203K Buy
+4,166
New +$194K 0.05% 245

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wintrust Investments's GSK Position: Q4 2024 in Review

Wintrust Investments reduced its GSK (GSK) stake by 46% in Q4 2024, selling an estimated $19.7K and leaving 645 shares worth $21K. The position accounts for 0.02% of the portfolio, ranked #385.

Wintrust Investments first reported a position in GSK in Q1 2018 and has held it in 25 quarters since. The position peaked at $1.74M in Q1 2021. 849 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Wintrust Investments held 645 shares of GSK worth $21K as of Q4 2024.
  • Wintrust Investments sold 547 GSK shares in Q4 2024, an estimated $19.7K.
  • GSK made up 0.02% of Wintrust Investments's portfolio in Q4 2024, its #385 holding.
  • Wintrust Investments first reported a position in GSK in Q1 2018 and has held it in 25 quarters since.
  • Wintrust Investments's GSK position peaked at $1.74M in Q1 2021.
  • 849 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.